Rx Safes Assigned Ticker Symbol, Ships First Orders of 2015

HENDERSON, NV--(Marketwired - Jan 29, 2015) - Rx Safes, Inc. (OTC: RXSF), the developer of fingerprint enabled healthcare security products and secure prescription medicine lock-boxes, announced today that it has entered a new chapter in the company's growth with the issuance of its ticker symbol and the commencement of trading its company stock. The company also announced today that it has shipped 500 units of the Rx DrugSAFE prescription drug lock-box to the Oklahoma Bureau of Narcotics and Drug Diversion, fulfilling its first order of 2015.

Rx Safes, Inc. is positioned to make a huge impact on the way families and healthcare facilities store potentially dangerous medicines, reducing abuse, reducing overdose and lowering healthcare costs associated with those issues.

The Company previously received a Purchase Order issued by the State of Oklahoma for 500 units of the Rx DrugSAFE. The Rx DrugSAFE is a fingerprint secured steel lock box designed to prevent unauthorized access to prescription and other potentially dangerous medicines and will be distributed by the State of Oklahoma to at risk families. "The order from Oklahoma Bureau of Narcotics demonstrates the Rx DrugSAFE's important role in preventing theft or unauthorized misuse of prescription drugs," commented Lorraine Yarde, CEO of Rx Safes, Inc. "We believe our patented fingerprint technology is a game changer in offering a real security solution that is simple and convenient to use, which will aid in the overall adoption of our products in the home, as well in healthcare facilities. With a funding source identified through a Federal program available to all of the States, we believe other States will follow Oklahoma's lead in providing a real solution to prevent access to potentially deadly drugs and Rx Safes will be taking a pro-active role in an effort to pursue this," Ms. Yarde added.

"Prescription drug abuse and addiction claims more than 600 lives each year in Oklahoma. Many of these deaths and overdoses are the result of medication stolen out of home medicine cabinets by teens, relatives or friends with an opioid addiction. We encourage anyone with prescription drugs in the home to lock them up. These prescription drug safes will accomplish our mission of keeping necessary medication from getting in the wrong hands and preventing prescription drug overdoses and deaths," stated Darrell Weaver, OBN Director.

The company expects to introduce several new products addressing drug abuse and diversion in 2015 utilizing the company's patented technology.

About Rx Safes, Inc.

Rx Safes develops, manufactures and markets professional grade drug security solutions for families and the healthcare community, incorporating proprietary, patented fingerprint technology, designed for heightened security and convenience. Marketed under the Rx DrugSAFE brand, our products prevent unauthorized access to drugs while maintaining convenient access for the prescribed users. Founded in 2010, the Company is concentrating on prescription (Rx) and over the counter (OTC) drug security, providing real solutions to address the Rx and OTC abuse epidemic plaguing our society. For more information about the Rx DrugSAFE, please visit http://www.rxdrugsafe.com

Forward-Looking Statements for RXSF:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Like us on Facebook at https://www.facebook.com/rx.drugsafe
Follow us on Twitter at https://twitter.com/RxDrugSAFE